HK Inno N Corp
195940
Company Profile
Business description
HK Inno N Corp operates in the Ethical Drugs (ETC) and Health & Beauty (H&B) businesses. Key products in the ETC sector include K-Cap, Lovajet, and Akinzio, while key products in the H&B sector include Condition, Hogaesu, and B-Ones. The company operates in two segments: Pharmaceutical division; and Health and Beauty division. It generates maximum revenue from Pharmaceutical division. Geographically, it operates in Domestic and Foreign markets.
Contact
No. 239, Osongsaengmyeong 2-ro
Osong-eup, Heungdeok-gu
Chungcheongbuk-do
Cheongju-si
KORT: +82 3151764000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
1,703
Stocks News & Analysis
stocks
The World Cup stock you’ve never heard of
This ASX stock is kicking goals at the FIFA World Cup.
stocks
Chart of the Week: Can WiseTech shares finally bounce back?
Market concerns over governance and AI fears have left shares trading well below the fair value.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,003.70 | 34.90 | 0.39% |
| CAC 40 | 8,332.32 | 5.70 | 0.07% |
| DAX 40 | 25,148.20 | 29.93 | 0.12% |
| Dow JONES (US) | 52,487.41 | 139.02 | 0.27% |
| FTSE 100 | 10,482.86 | 10.41 | 0.10% |
| HKSE | 24,175.12 | 144.94 | 0.60% |
| NASDAQ | 26,206.89 | 336.24 | 1.30% |
| Nikkei 225 | 68,557.73 | 813.88 | 1.20% |
| NZX 50 Index | 13,785.67 | 120.49 | 0.88% |
| S&P 500 | 7,543.64 | 60.93 | 0.81% |
| S&P/ASX 200 | 8,806.00 | 38.20 | 0.44% |
| SSE Composite Index | 3,996.16 | 40.43 | -1.00% |